These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33275488)

  • 1. Addressing the Dilemma of Contralateral Prophylactic Mastectomy With Behavioral Science.
    Sacks GD; Morrow M
    J Clin Oncol; 2021 Feb; 39(4):269-272. PubMed ID: 33275488
    [No Abstract]   [Full Text] [Related]  

  • 2. An Evaluation of the Choice for Contralateral Prophylactic Mastectomy and Patient Concerns About Recurrence in a Reconstructed Cohort.
    Sando IC; Billig JI; Ambani SW; Kraft CT; Kidwell KM; Zhong L; Chung KC; Momoh AO
    Ann Plast Surg; 2018 Apr; 80(4):333-338. PubMed ID: 29166308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASO Author Reflections: What Drives Contralateral Prophylactic Mastectomy?
    Schellenberg AE; Scheer AS
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):821-822. PubMed ID: 31667725
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of anticipated financial burden on patient decision to undergo contralateral prophylactic mastectomy.
    Huang J; Chagpar A
    Surgery; 2018 Oct; 164(4):856-865. PubMed ID: 30093279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral Prophylactic Mastectomy and Immediate Breast Reconstruction in High-Risk Women: The Importance of Health-Related Quality of Life in Decision Making.
    Lemaine V
    Ann Surg Oncol; 2017 Sep; 24(9):2434-2435. PubMed ID: 28600730
    [No Abstract]   [Full Text] [Related]  

  • 6. Contralateral prophylactic mastectomy: A qualitative approach to exploring the decision making process.
    Greener JR; Bass SB; Lepore SJ
    J Psychosoc Oncol; 2018; 36(2):145-158. PubMed ID: 29064771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Emotion in Cancer Surgery Decisions: Applying Concepts From Decision Psychology.
    Lee CN; Merrill AL; Peters E
    Ann Surg; 2021 Jun; 273(6):e265-e267. PubMed ID: 33156060
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
    Huang J; Chagpar A
    Am J Surg; 2019 Jul; 218(1):170-174. PubMed ID: 30554666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
    Tollow P; Williams VS; Harcourt D; Paraskeva N
    Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of decision-making resources on satisfaction with decision to undergo contralateral prophylactic mastectomy (CPM).
    Huang J; Chagpar A
    Am J Surg; 2020 Jun; 219(6):1036-1038. PubMed ID: 31570198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.
    Montagna G; Morrow M
    Expert Rev Anticancer Ther; 2020 Mar; 20(3):159-166. PubMed ID: 32077338
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
    Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
    Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
    Huang J; Chagpar A
    J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
    Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining Risk and Benefit: Understanding the Decision to Undergo Contralateral Prophylactic Mastectomy.
    Rendle KA; Halley MC; May SG; Frosch DL
    Qual Health Res; 2015 Sep; 25(9):1251-9. PubMed ID: 25371380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
    Terkelsen T; Rønning H; Skytte AB
    Acta Oncol; 2020 Jan; 59(1):60-65. PubMed ID: 31379231
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of a template for psychological assessment of women considering risk-reducing or contralateral prophylactic mastectomy: A national Delphi consensus study.
    Braude L; Kirsten L; Gilchrist J; Juraskova I
    Psychooncology; 2018 Oct; 27(10):2349-2356. PubMed ID: 29966172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy.
    Venetis MK; MacGeorge EL; Baptiste DF; Mouton A; Friley LB; Pastor R; Hatten K; Lagoo J; Bowling MW; Clare SE
    Am J Clin Oncol; 2018 Jun; 41(6):519-525. PubMed ID: 27465657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral prophylactic mastectomy: What should not be forgotten to improve communication between clinicians and patients!
    Franceschini G; Di Leone A; Masetti R
    Patient Educ Couns; 2019 Aug; 102(8):1573-1574. PubMed ID: 30905494
    [No Abstract]   [Full Text] [Related]  

  • 20. Contralateral prophylactic mastectomy.
    Benson JR; Winters ZE
    Br J Surg; 2016 Sep; 103(10):1249-50. PubMed ID: 27465285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.